From addiction and heart disease to liver disease and sleep apnea, it seems like there's nothing that these new weight-loss ...

Tirzepatide, a weekly GLP-1 and GIP drug, produced weight loss of up to 17.8% after 72 weeks. Semaglutide, a weekly GLP-1 ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

An estimated 24 million Americans will use these weight loss drugs by 2035, posing significant challenges as well as ...

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

Nestle, the world’s largest producer of packaged food, just rolled out a new protein shot drink that it says will help people ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs ...

With the soaring popularity of drugs like Ozempic, the market is ripe for disruption,” researcher Rubina Aktar said.

Taking a glp-1 medication for weight loss isn't appropriate for everyone. There are side effects and costs to consider.

These weight management drugs, which mimic natural hormones that regulate insulin and glucose levels, have become increasingly popular due to their effectiveness in promoting weight loss. However, ...